Srinivas Akkaraju

Investment Partner

Overview

Gender
male
Investor Type
Investment Partner

Akkaraju founded Samsara BioCapital in 2017, and has more than 18 years of investment and operational experience in the Life Sciences sector. Most recently, he was a General Partner at Sofinnova Ventures and concentrated on biopharmaceutical investments. Previously, he was Managing Director at New Leaf Venture Partners, a co-founder and Managing Director at Panorama Capital, and served as Partner of J.P. Morgan Partners. He held business and corporate development positions at Genentech. Dr. Akkaraju also serves as a director of aTyr Pharma, Intercept Pharmaceuticals, Seattle Genetics and Versartis. Dr. Akkaraju received B.A. degrees in biochemistry and computer science from Rice University and an M.D. and Ph.D. in Immunology from Stanford University School of Medicine.

Jobs

Number of Current Jobs
2
Srinivas Akkaraju has 2 current jobs including Board Member at Seagen , Board of Directors at Tentarix Biotherapeutics and .
Organization Name Title At Company Start Date End Date
Seagen Board Member Detail
Tentarix Biotherapeutics Board of Directors Detail